Global increase in aging population, retention of dentition and increased rehabilitation with complex implant supported restorations will soon increase demand for prevention and maintenance. Are the “tools and potions” for prevention and maintenance we have so far sufficient to satisfy demands of future patients? Mechanical biofilm control is mainstream in prevention of most common oral diseases; however, chemical biofilm control may be necessary to implement as an adjunct in certain cases.
Numerous products for chemical biofilm control are commercially available, but not all of them have been proven effective in clinical practice.
Due to emerging evidence related to increased adverse effects, the search for avenues in designing new agents for chemical control of biofilm is underway.
The webinar will discuss the use of chemical plaque control in dental clinical practice.
It will focus on the following aspects:
- Understanding mechanisms of action of oral antiseptics commonly used in dental clinical practice
- Evidence-based use of oral antiseptics for various clinical indications
- Understanding and minimizing their adverse effects
- Busting myths with most recent research evidence
- Exploring new directions in designing “rinse” of the new age
Tribune Group GmbH is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Tribune Group designates this activity for 1 continuing education credits.
This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between Tribune Group GmbH and Dental Tribune International GmbH.
Share on social media:
